Evidence map›Paper›PMID 33936367›Full record

ArticleInternational journal of clinical and experimental pathology2021

Refractory multiple myeloma with extramedullary plasmacytoma of the spleen and suspicious teratoma: a rare case report and literature review.

Peipei Xu, Hong Chu, Xiaoyan Shao, Ying Jiang, Chaoyang Guan, Ming Chen, Bing Chen

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Peipei XuDepartment of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing, PR China.
Hong ChuDepartment of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing, PR China.
Xiaoyan ShaoDepartment of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing, PR China.
Ying JiangDepartment of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing, PR China.
Chaoyang GuanDepartment of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing, PR China.
Ming ChenDepartment of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School Nanjing, PR China.
Bing ChenDepartment of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing, PR China.
Nanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple myeloma (MM) is a type of malignant disease that is characterized by a clonal proliferation of plasma cells within the bone marrow. Relapsed and refractory multiple myeloma (RRMM) is a subtype of MM that is unreactive to salvage therapy and progresses during treatment or within 60 days of the last therapy in patients who achieved a minimal response before progression of disease. This usually results in a poor prognosis. Extramedullary plasmacytoma (EMP) occurs when MM occasionally develops in tissues other than bones marrow. To the best of our knowledge, case studies of the presence of EMPs in the spleen have rarely been reported. Teratoma is a type of congenital tumor that consists of tissue that arises from pluripotent embryonic cells. Here we report a case of refractory immunoglobulin G (IgG) MM with both splenic plasmacytomas and a suspicious teratoma. To investigate the clinical and treatment features of patients under similar conditions, we also reviewed the available literature supporting the useful information in the pathogenesis, diagnosis and treatment of RRMM with EMP.

Indexed as

Multiple myelomaprimary extramedullary plasmacytomasteratoma

Identifiers

PMID33936367
PMCPMC8085831
OpenAlexW3157426426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.